We recognise the trust our investors place in us and it's not a responsibility we take lightly.

Fisher & Paykel Healthcare
FY 2024 Full Year Results Announcement

29 May at 10.00am NZST (8.00am AEST; 6.00pm USEDT, Tuesday, 28 May)
FPH 2024 Annual Report

Annual Report 2024

Annual report for Fisher & Paykel Healthcare for the 2024 financial year.

View report

Latest Investor News

2024/25 Key Dates

For more information visit our events page

31 March 2024
2024 Financial Year End

29 May 2024
Full Year Results Announcement

10 July 2024
Full Year Dividend

28 August 2024
Annual Shareholders Meeting

† Dividends are subject to Board determination

30 September 2024
Financial Half Year End

November 2024
Half Year Results Announcement

December 2024
Interim Dividend

Share Price



Daily volume

Annual average daily

52 week range


Compare with:

Chart Last Updated:
FPH 2024 Investor Fact Sheet

Investor Fact Sheet

A short overview of Fisher & Paykel Healthcare's history, financial performance, business areas and management team.

View the investor fact sheet

Investor Information

Shareholders should address questions relating to dividends, certificates or changes of address to Fisher & Paykel Healthcare's share registrar, Link Market Services Limited.


New Zealand

LINK Market Services Limited
Level 7, Zurich House
21 Queen Street
Auckland 1010
P O Box 91976
Auckland 1142
Investor enquiries: +64 9 375 5998
Fax: +64 9 375 5990



LINK Market Services Limited
Level 12, 680 George Street
Sydney, NSW 2000
Locked Bag A14
Sydney South
NSW 1235
Investor enquiries: +61 2 8280 7111
Fax: +61 2 9287 0303

For all other investor inquiries contact 

Email: investor@fphcare.co.nz

Phone: +64 9 574 0123 Ext: 5396

Fisher & Paykel Healthcare
15 Maurice Paykel Place
East Tamaki, Auckland 2013
PO Box 14 348
Panmure, Auckland 1741
New Zealand



Fisher & Paykel Healthcare is listed on the NZX Main Board and Australian Securities Exchange and is governed by the rules of those exchanges. Fisher & Paykel Healthcare does not sponsor, sanction, support or encourage trading in Fisher & Paykel Healthcare shares through third and fourth markets, such as ADR programmes and over the counter trading. Fisher & Paykel Healthcare disclaims any liability whatsoever arising out of any trading through third and fourth markets, including unsponsored ADR programmes and over the counter trading.

Subscribe to Investor Alerts

Sign up to receive email notifications of the latest investor news from Fisher & Paykel Healthcare.